These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3092723)

  • 21. Clinical value of the determination of serum guanase activity in acute myocardial infarction.
    Ito S; Takaoka T; Kishi S; Sato H; Matsuhisa M; Nakaya Y; Hiasa Y; Murayama Y; Ueda S; Mori H; Murakami T; Kagawa M
    Tokushima J Exp Med; 1978 Jul; 25(1-2):29-35. PubMed ID: 725916
    [No Abstract]   [Full Text] [Related]  

  • 22. Posttransfusion hepatitis in Japan.
    Takano S; Omata M; Ohto M; Satomura Y
    Vox Sang; 1992; 62(3):156-64. PubMed ID: 1609517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simple, rapid determination of serum guanase activity with the Hitachi 736 automated discrete analyzer.
    Nishikawa Y; Fukumoto K; Watanabe F
    Clin Chem; 1985 Jan; 31(1):103-5. PubMed ID: 2981163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sensitive new method for measurement of guanase with 8-azaguanine in bicine bis-hydroxy ethyl glycine buffer as substrate.
    Ito S; Takaoka T; Mori H; Teruo A
    Clin Chim Acta; 1981 Sep; 115(2):135-44. PubMed ID: 7285360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significance of guanase analysis in biochemical laboratory tests].
    Ito S
    Nihon Rinsho; 1989 Dec; 48 Suppl():264-6. PubMed ID: 2621882
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and laboratory-based evaluation of serum guanase activity in liver diseases].
    Matsumoto K; Sugiuchi H; Yamane N; Sagara K
    Rinsho Byori; 1986 Sep; 34(9):1059-64. PubMed ID: 3795539
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum bile acids and alanine aminotransferase concentrations. Comparison of efficacy as indirect means of identifying carriers of non-A, non-B hepatitis agents and of onset, severity, and duration of posttransfusion non-A, non-B hepatitis in recipients.
    Mishler JM; Barbosa L; Mihalko LJ; McCarter H
    JAMA; 1981 Nov; 246(20):2340-4. PubMed ID: 6795368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis.
    Hoyos M; Sarrión JV; Pérez-Castellanos T; Prieto M; Marty ML; Garrigues V; Berenguer J
    Hepatology; 1989 Mar; 9(3):449-51. PubMed ID: 2493415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical application of serum guanase analysis by electrophoresis].
    Nishikawa Y; Ono N; Fukumoto K; Watanabe F
    Rinsho Byori; 1988 Nov; 36(11):1313-6. PubMed ID: 3249394
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetic measurement of guanine deaminase in serum with a centrifugal analyzer.
    Nishikawa Y; Fukumoto K
    Clin Chem; 1981 Apr; 27(4):560-1. PubMed ID: 7471421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cause and frequency of posttransfusion hepatitis after open-heart surgery.
    Schlayer HJ; Peters T; Preisler S; Berthold H; Gerok W; Rasenack J
    Clin Investig; 1992 Jul; 70(7):579-84. PubMed ID: 1392426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of blood transfusion in non-A, non-B chronic liver disease in Japan.
    Kiyosawa K; Akahane Y; Nagata A; Koike Y; Furuta S
    Vox Sang; 1982 Jul; 43(1):45-52. PubMed ID: 6287737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of serum guanase in hepatic diseases.
    Kuzmits R; Seyfried H; Wolf A; Müller MM
    Enzyme; 1980; 25(3):148-52. PubMed ID: 6105073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
    Takano S; Omata M; Ohto M; Satomura Y
    Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis.
    Resnick RH; Stone K; Antonioli D
    Dig Dis Sci; 1983 Oct; 28(10):908-11. PubMed ID: 6193933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple ultraviolet spectrophotometric method for the determination of serum guanase activity.
    Yasmineh WG
    Clin Biochem; 1988 Aug; 21(4):239-43. PubMed ID: 3409526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-A, non-B posttransfusion hepatitis--a decade later.
    Koretz RL; Stone O; Mousa M; Gitnick GL
    Gastroenterology; 1985 May; 88(5 Pt 1):1251-4. PubMed ID: 3920112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorimetric determination of serum guanase activity.
    Caraway WT
    Clin Chem; 1966 Apr; 12(4):187-93. PubMed ID: 4952427
    [No Abstract]   [Full Text] [Related]  

  • 39. [Occurrence of non-A, non-B post-transfusion hepatitis in heart surgery. Prospective study on the value of the determination of serum alanine aminotransferase and detection of anti-HBc antibodies in blood donors].
    Gayet S; Aymard JP; Janot C; Guillemin C; Briquel ME; Gaucher P; Streiff F
    Rev Fr Transfus Immunohematol; 1986 Dec; 29(6):485-94. PubMed ID: 3108992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.
    Spinella PC; Perkins JG; Grathwohl KW; Repine T; Beekley AC; Sebesta J; Jenkins D; Azarow K; Holcomb JB;
    Crit Care Med; 2007 Nov; 35(11):2576-81. PubMed ID: 17828033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.